Tilray Brands Inc
XETRA:2HQ0
Tilray Brands Inc
XETRA:2HQ0
Price:
6.74
EUR
0.15%
Market Closed
Market Cap:
€781.8m
Relative Value
The Relative Value of one
2HQ0
stock under the Base Case scenario is
8.75
EUR.
Compared to the current market price of 6.74 EUR,
Tilray Brands Inc
is
Undervalued by 23%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
2HQ0
Relative Value
Base Case
8.75
EUR
Undervaluation 23%
Multiples Across Competitors
2HQ0 Competitors Multiples
Tilray Brands Inc Competitors
Tilray Brands Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Tilray Brands Inc
XETRA:2HQ0
|
785.4m EUR | 1.1 | -0.4 | 17.6 | -11.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
987.9B USD | 15.2 | 47.9 | 32.3 | 34.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.5B USD | 6.3 | 22.3 | 15.4 | 19 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
293B CHF | 4.8 | 31.2 | 13.1 | 15.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
249.7B CHF | 5.7 | 23 | 14.2 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
240.5B GBP | 5.5 | 31.7 | 17.5 | 24.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
307.4B USD | 4.7 | 16.8 | 10.5 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.9B USD | 2.5 | 20.2 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD | 2.6 | 17.8 | 7.4 | 9.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
